Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Durata Therapeutics, Inc. 

89 Headquarters Plaza North
Suite 306
Morristown  New Jersey  07960  U.S.A.
Phone: 646-871-6480 Fax: 973-993-4865



 Company News
PDL BioPharma, Inc. (PDLI) Announces Successful Conclusion Of Debt Financing Agreement With Durata Therapeutics, Inc.  (DRTX) 11/19/2014 3:52:22 PM
Karmanos Cancer Institute Honored By Michigan Cancer Consortium With Spirit Of Collaboration Award 11/18/2014 1:18:25 PM
Actavis (ACT) Successfully Completes Durata Therapeutics, Inc.  (DRTX) Tender Offer 11/17/2014 11:49:35 AM
Actavis (ACT) And Durata Therapeutics, Inc.  (DRTX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Durata 11/3/2014 7:28:53 AM
Durata Therapeutics, Inc.  (DRTX) Presents New Data For DALVANCE™ At IDWeek 2014 10/13/2014 7:39:13 AM
Actavis (ACT) Finally Makes A Move, Pays $675 Million For Durata Therapeutics, Inc.  (DRTX) 10/6/2014 6:19:48 AM
FDA Grants Durata Therapeutics, Inc.  (DRTX) A Special Protocol Agreement (SPA) For Its Phase 3 Study Of DALVANCE(TM) In Hospitalized Community-Acquired Pneumonia 10/3/2014 7:12:13 AM
Durata Therapeutics, Inc.  (DRTX) To Present Five Posters At IDWeek 2014 10/2/2014 10:26:33 AM
Durata Therapeutics, Inc.  (DRTX) Presented Data At The 54th Interscience Conference On Antimicrobial Agents And Chemotherapy (ICAAC) 9/9/2014 8:59:00 AM
Durata Therapeutics, Inc.  (DRTX) To Present Safety And Efficacy Data At The 54th Interscience Conference On Antimicrobial Agents And Chemotherapy (ICAAC) 9/3/2014 7:55:08 AM